Research Topics
| Dan H BarouchSummaryAffiliation: Harvard University Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001)Dan H Barouch
Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA
J Infect Dis 207:248-56. 2013..ENVA.01), are reported concurrently with this article. Here, we characterize in greater detail the humoral and cellular immune responses elicited by Ad26.ENVA.01 in humans...
Macaque studies of vaccine and microbicide combinations for preventing HIV-1 sexual transmissionDan H Barouch
Beth Israel Deaconess Medical Center, Boston, MA 02115, USA
Proc Natl Acad Sci U S A 109:8694-8. 2012..Overall, the data suggest that vaccines and microbicides are complementary techniques that may protect better when used together than separately...
Adenovirus serotype 5 neutralizing antibodies target both hexon and fiber following vaccination and natural infectionRitu R Bradley
Division of Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
J Virol 86:625-9. 2012..A novel chimeric Ad5 vector in which both the hexon HVRs and the fiber knob were exchanged nearly completely evaded Ad5-specific NAbs both in vitro and in vivo...
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeysDan H Barouch
Division of Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
Nature 482:89-93. 2012..These data demonstrate the proof-of-concept that optimized HIV-1 vaccine candidates can block acquisition of stringent, heterologous, neutralization-resistant virus challenges in rhesus monkeys...
Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeysDan H Barouch
Division of Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
Nat Med 16:319-23. 2010..Polyvalent mosaic antigens therefore represent a promising strategy to expand cellular immunologic vaccine coverage for genetically diverse pathogens such as HIV-1...
Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunityDan H Barouch
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
J Immunol 172:6290-7. 2004..Moreover, these studies suggest that using Ad vectors derived from immunologically distinct serotypes may be an effective and general strategy to overcome the suppressive effects of pre-existing anti-Ad immunity...
HIV escape from cytotoxic T lymphocytes: a potential hurdle for vaccines?Dan H Barouch
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
Lancet 364:10-1. 2004
HIV-1 vaccine development after STEPDan H Barouch
Division of Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02115, USA
Annu Rev Med 61:153-67. 2010..We review the current state of the HIV-1 vaccine field and outline strategies that are being explored to overcome these roadblocks...
Expression kinetics of the interleukin-2/immunoglobulin (IL-2/Ig) plasmid cytokine adjuvantDan H Barouch
Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA
Vaccine 22:3092-7. 2004....
Protective efficacy of a single immunization of a chimeric adenovirus vector-based vaccine against simian immunodeficiency virus challenge in rhesus monkeysDan H Barouch
Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA
J Virol 83:9584-90. 2009..Inclusion of Env resulted in improved control of peak and set point SIV RNA levels following challenge. In contrast, DNA vaccine priming did not further improve the protective efficacy of rAd5HVR48 vectors in this system...
Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variantsDan H Barouch
Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, Massachusetts 02215, USA
Nat Immunol 6:247-52. 2005....
Adenovirus vector-based vaccines for human immunodeficiency virus type 1Dan H Barouch
Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
Hum Gene Ther 16:149-56. 2005..In this review, we describe progress in the development of rAd vector-based vaccines with a focus on human immunodeficiency virus type 1...
Challenges in the development of an HIV-1 vaccineDan H Barouch
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
Nature 455:613-9. 2008..Here I review key challenges and future prospects in the quest to develop a prophylactic HIV-1 vaccine...
Plasmid chemokines and colony-stimulating factors enhance the immunogenicity of DNA priming-viral vector boosting human immunodeficiency virus type 1 vaccinesDan H Barouch
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
J Virol 77:8729-35. 2003..These data demonstrate that plasmid cytokines can markedly improve the immunogenicity of DNA prime-viral vector boost vaccine strategies and can partially compensate for antivector immunity...
Rational design of gene-based vaccinesDan H Barouch
Research East Room 113, Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
J Pathol 208:283-9. 2006..In this review, current strategies to develop and optimize gene-based vaccines are described, with an emphasis on novel approaches to improve plasmid DNA vaccines and recombinant adenovirus vector-based vaccines...
Bovine adenovirus vectored vaccine for avian influenzaDan H Barouch
Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
Mol Ther 16:807-8. 2008
International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populationsDan H Barouch
Division of Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
Vaccine 29:5203-9. 2011..These data inform the clinical development of alternative serotype rAd vaccine vectors in the developing world...
Viral escape from dominant simian immunodeficiency virus epitope-specific cytotoxic T lymphocytes in DNA-vaccinated rhesus monkeysDan H Barouch
Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
J Virol 77:7367-75. 2003..These data suggest that CTL exert selective pressure on viral replication and that viral escape from CTL may be a limitation of CTL-based AIDS vaccine strategies...
Novel adenovirus vector-based vaccines for HIV-1Dan H Barouch
Division of Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
Curr Opin HIV AIDS 5:386-90. 2010..These vectors are being explored as potential vaccine candidates for a variety of pathogens. This review summarizes current efforts to develop rAd vector-based vaccines for HIV-1...
Replication-defective adenovirus serotype 5 vectors elicit durable cellular and humoral immune responses in nonhuman primatesSampa Santra
Division of Viral Pathogenesis, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, RE113, P. O. Box 15732, Boston, MA 02215, USA
J Virol 79:6516-22. 2005..Therefore, administration of ADV5-based vectors in DNA-primed subjects may be a preferred use of this vaccine modality for generating long-term immune protection...
Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccinesShawn M Sumida
Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
J Clin Invest 114:1334-42. 2004..Synergistic recruitment and expansion of DCs in vivo may prove a practical strategy for overcoming this limitation and potentiating immune responses to vaccines as well as other immunotherapeutic strategies...
Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and DPeter Abbink
Research East Room 213, Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA
J Virol 81:4654-63. 2007..These studies substantially expand the portfolio of rare serotype rAd vectors that may prove useful as vaccine vectors for the developing world...
Trafficking of antigen-specific CD8+ T lymphocytes to mucosal surfaces following intramuscular vaccinationDavid R Kaufman
Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
J Immunol 181:4188-98. 2008..Thus, i.m. vaccination can overcome immune compartmentalization and generate robust mucosal CD8(+) T lymphocyte memory. These data demonstrate that the systemic and mucosal immune systems are highly coordinated following vaccination...
Magnitude and phenotype of cellular immune responses elicited by recombinant adenovirus vectors and heterologous prime-boost regimens in rhesus monkeysJinyan Liu
Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
J Virol 82:4844-52. 2008..Moreover, qualitative differences in cellular immune responses may prove critical in determining the overall potency of heterologous rAd prime-boost regimens...
Immunogenicity of recombinant Modified Vaccinia Ankara following a single or multi-dose vaccine regimen in rhesus monkeysLauren E Grandpre
Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Boston, MA 02215, United States
Vaccine 27:1549-56. 2009..Together, these studies suggest that a multi-dose vaccine regimen utilizing up to four inoculations of MVA generates robust and durable antibody-mediated immunity comparable to that elicited by replication-competent VV...
Dysfunction of simian immunodeficiency virus/simian human immunodeficiency virus-induced IL-2 expression by central memory CD4+ T lymphocytesYue Sun
Division of Viral Pathogenesis, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA
J Immunol 174:4753-60. 2005..Persisting clinical protection in vaccinated and challenged monkeys is thus correlated with a preserved capacity of the peripheral blood central memory CD4+ T cells to express this important immunomodulatory cytokine...
Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeysJinyan Liu
Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
Nature 457:87-91. 2009..These findings have important implications for the development of next-generation T-cell-based vaccine candidates for HIV-1...
Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon proteinShawn M Sumida
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
J Immunol 174:7179-85. 2005..These studies suggest a potential strategy for engineering novel Ad5 vectors to evade dominant Ad5-specific NAbs...
Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytesDan H Barouch
Department of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, Research East Room 113, 330 Brookline Avenue, Boston, Massachusetts 02215, USA
Nature 415:335-9. 2002..These data indicate that viral escape from CTL recognition may be a major limitation of the CTL-based AIDS vaccines that are likely to be administered to large human populations over the next several years...
Global dysfunction of CD4 T-lymphocyte cytokine expression in simian-human immunodeficiency virus/SIV-infected monkeys is prevented by vaccinationPaul F McKay
Division of Viral Pathogenesis, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
J Virol 77:4695-702. 2003....
Prior vaccination increases the epitopic breadth of the cytotoxic T-lymphocyte response that evolves in rhesus monkeys following a simian-human immunodeficiency virus infectionSampa Santra
Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
J Virol 76:6376-81. 2002..These data indicate that prior vaccination can increase the breadth of the CTL response that evolves after an AIDS virus infection...
Immunogenicity of recombinant fiber-chimeric adenovirus serotype 35 vector-based vaccines in mice and rhesus monkeysAnjali Nanda
Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, Massachusetts 02215, USA
J Virol 79:14161-8. 2005..Moreover, these studies demonstrate that capsid chimeric rAd vectors can be constructed to combine beneficial immunologic and serologic properties of different Ad serotypes...
Neutralizing antibodies and CD8+ T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectorsShawn M Sumida
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
J Virol 78:2666-73. 2004..Novel adenovirus vectors that are currently being developed to circumvent the problem of preexisting anti-Ad5 immunity should therefore be designed to evade both humoral and cellular Ad5-specific immune responses...
Mucosal trafficking of vector-specific CD4+ T lymphocytes following vaccination of rhesus monkeys with adenovirus serotype 5Katherine Masek-Hammerman
New England Primate Research Center, Harvard Medical School, Southborough, Massachusetts 017721, USA
J Virol 84:9810-6. 2010....
Recombinant poxvirus boosting of DNA-primed rhesus monkeys augments peak but not memory T lymphocyte responsesSampa Santra
Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA
Proc Natl Acad Sci U S A 101:11088-93. 2004..This study, therefore, indicates that the steady-state memory, rather than the peak effector vaccine-elicited T lymphocyte responses, may be the critical immune correlate of protection for a CTL-based HIV vaccine...
Low-dose mucosal simian immunodeficiency virus infection restricts early replication kinetics and transmitted virus variants in rhesus monkeysJinyan Liu
Division of Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
J Virol 84:10406-12. 2010..These findings have implications for the design and interpretation of HIV-1 vaccine efficacy studies...
Vaccine protection against functional CTL abnormalities in simian human immunodeficiency virus-infected rhesus monkeysPaul F McKay
Division of Viral Pathogenesis, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA
J Immunol 168:332-7. 2002..Moreover, an AIDS vaccine that confers protection against clinical disease evolution in this experimental model also preserves the functional capacity of these CTL to produce both IL-2 and TNF-alpha...
TLR4 ligands augment antigen-specific CD8+ T lymphocyte responses elicited by a viral vaccine vectorElizabeth G Rhee
Division of Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
J Virol 84:10413-9. 2010..Moreover, these findings suggest the potential utility of TLR4 ligands as adjuvants for rAd vector-based vaccines...
A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primatesDan H Barouch
Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
J Virol 79:8828-34. 2005..This strategy could therefore be explored as a potential method to enhance DNA vaccine immunogenicity in humans...
Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunityDiane M Roberts
Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
Nature 441:239-43. 2006..Such chimaeric viral vectors may have important practical implications for vaccination and gene therapy...
Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humansKara L O'Brien
Division of Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
Nat Med 15:873-5. 2009..These findings challenge the hypothesis that activated Ad5-specific T lymphocytes were the cause of the potential enhanced HIV-1 susceptibility in the STEP study...
Immunogenicity of heterologous recombinant adenovirus prime-boost vaccine regimens is enhanced by circumventing vector cross-reactivityAnna R Thorner
Research East Room 213, Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA
J Virol 80:12009-16. 2006....
Use of molecular beacons for rapid, real-time, quantitative monitoring of cytotoxic T-lymphocyte epitope mutations in simian immunodeficiency virusFred W Peyerl
Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
J Clin Microbiol 43:4773-9. 2005..This real-time PCR technique for evaluating CTL epitope mutations may prove to be a useful tool for monitoring the genetic drift of human immunodeficiency virus and SIV in infected individuals...
Recruitment of different subsets of antigen-presenting cells selectively modulates DNA vaccine-elicited CD4+ and CD8+ T lymphocyte responsesPaul F McKay
Division of Viral Pathogenesis, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston 02215, USA
Eur J Immunol 34:1011-20. 2004..Moreover, these studies show that different subsets of professional APC can selectively modulate DNA vaccine-elicited T lymphocyte responses...
Magnitude and diversity of cytotoxic-T-lymphocyte responses elicited by multiepitope DNA vaccination in rhesus monkeysRamu A Subbramanian
Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Research East-RE 113, 330 Brookline Avenue, Boston, MA 02215, USA
J Virol 77:10113-8. 2003..These studies suggest that multiepitope plasmid DNA vaccine-based prime-boost regimens can efficiently prime for CTL responses of increased breadth and magnitude, although they do not overcome predicted hierarchies of immunodominance...
Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSFDan H Barouch
Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
J Immunol 168:562-8. 2002..These results demonstrate that bicistronic DNA vaccines containing GM-CSF elicit remarkably potent CD4(+) T cell responses and suggest that optimal Th cell priming requires the precise temporal and spatial codelivery of Ag and GM-CSF...
A centralized gene-based HIV-1 vaccine elicits broad cross-clade cellular immune responses in rhesus monkeysSampa Santra
Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA
Proc Natl Acad Sci U S A 105:10489-94. 2008..These findings suggest that immunization with centralized genes is a promising vaccine strategy for developing a global vaccine for HIV-1 as well as vaccines for other genetically diverse viruses...
Route of adenovirus-based HIV-1 vaccine delivery impacts the phenotype and trafficking of vaccine-elicited CD8+ T lymphocytesDavid R Kaufman
Division of Vaccine Research, Beth Israel Deaconess Medical Center, E CLS 1047, 330 Brookline Avenue, Boston, MA 02215, USA
J Virol 84:5986-96. 2010..m. or i.n. rAd immunization. Our findings indicate that the anatomic microenvironment of antigen expression critically impacts the phenotype and trafficking of antigen-specific CD8(+) T lymphocytes...
Adenovirus serotype 26 utilizes CD46 as a primary cellular receptor and only transiently activates T lymphocytes following vaccination of rhesus monkeysHualin Li
Division of Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
J Virol 86:10862-5. 2012..These data contribute to our understanding of Ad26 as a candidate vaccine vector...
Fitness costs limit viral escape from cytotoxic T lymphocytes at a structurally constrained epitopeFred W Peyerl
Harvard Medical School, Beth Israel Deaconess Medical Center, Division of Viral Pathogenesis, Research East Room 113, 330 Brookline Ave, Boston, MA 02215, USA
J Virol 78:13901-10. 2004....
Modulation of DNA vaccine-elicited CD8+ T-lymphocyte epitope immunodominance hierarchiesJinyan Liu
Research East Room 213, Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA
J Virol 80:11991-7. 2006....
Simian-human immunodeficiency virus escape from cytotoxic T-lymphocyte recognition at a structurally constrained epitopeFred W Peyerl
Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
J Virol 77:12572-8. 2003..Together, these data suggest that a compensatory mutation is selected for in SHIV strain 89.6P to facilitate the escape of that virus from CTL recognition of the dominant p11C, C-M epitope...
Durable mucosal simian immunodeficiency virus-specific effector memory T lymphocyte responses elicited by recombinant adenovirus vectors in rhesus monkeysHualin Li
Division of Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
J Virol 85:11007-15. 2011..Vaccine-elicited T(EM) responses at mucosal surfaces may prove critical for affording protection against invading pathogens at the mucosal portals of entry...
Differential antigen requirements for protection against systemic and intranasal vaccinia virus challenges in miceDavid R Kaufman
Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
J Virol 82:6829-37. 2008..These studies also suggest that rAd vectors warrant further assessment as candidate subunit smallpox vaccines...
Recruitment of antigen-presenting cells to the site of inoculation and augmentation of human immunodeficiency virus type 1 DNA vaccine immunogenicity by in vivo electroporationJinyan Liu
Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
J Virol 82:5643-9. 2008..Combining in vivo EP with plasmid chemokine adjuvants that similarly recruited APCs to the injection site, however, did not result in synergy...
Prospects for vaccine protection against HIV-1 infection and AIDSNorman L Letvin
Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA
Annu Rev Immunol 20:73-99. 2002..We then describe vaccine strategies that have been explored and discuss the evidence suggesting that cellular immune responses elicited by novel vaccine modalities may attenuate clinical disease caused by HIV-1...
HIV-1 envelope trimer elicits more potent neutralizing antibody responses than monomeric gp120James M Kovacs
Division of Molecular Medicine, Children s Hospital, Boston, MA 02115, USA
Proc Natl Acad Sci U S A 109:12111-6. 2012..These results, which demonstrate that there are relevant immunologic differences between monomers and high-quality envelope trimers, have important implications for HIV-1 vaccine development...
Full-length HIV-1 immunogens induce greater magnitude and comparable breadth of T lymphocyte responses to conserved HIV-1 regions compared with conserved-region-only HIV-1 immunogens in rhesus monkeysKathryn E Stephenson
Division of Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
J Virol 86:11434-40. 2012....
Adenovirus serotype 5-specific neutralizing antibodies target multiple hexon hypervariable regionsRitu R Bradley
Division of Vaccine Research, Beth Israel Deaconess Medical Center, and Ragon Institute of MGH, MIT and Harvard, Boston, Massachusetts, USA
J Virol 86:1267-72. 2012..These data have important implications for the development of novel vectors for both vaccines and gene therapy...
Safety and immunogenicity of therapeutic DNA vaccination in individuals treated with antiretroviral therapy during acute/early HIV-1 infectionEric S Rosenberg
Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America
PLoS ONE 5:e10555. 2010..clinicaltrials.gov NCT00125099)..
Age dependence of adenovirus-specific neutralizing antibody titers in individuals from sub-Saharan AfricaAnna R Thorner
Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Research East, Room 213, 330 Brookline Avenue, Boston, MA 02215, USA
J Clin Microbiol 44:3781-3. 2006..We observed a clear age dependence of Ad5-specific neutralizing antibody titers. These data will help to guide the development of Ad vector-based vaccines for human immunodeficiency virus type 1 and other pathogens...
Gag-specific cellular immunity determines in vitro viral inhibition and in vivo virologic control following simian immunodeficiency virus challenges of vaccinated rhesus monkeysKathryn E Stephenson
Division of Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
J Virol 86:9583-9. 2012..These data suggest the importance of including Gag in an HIV-1 vaccine in which virologic control is desired...
Accelerated heterologous adenovirus prime-boost SIV vaccine in neonatal rhesus monkeysJinyan Liu
Division of Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
J Virol 86:7829-35. 2012..These results suggest the potential of an accelerated heterologous rAd prime-boost regimen as a candidate HIV-1 vaccine for newborns...
Focus and breadth of cellular immune responses elicited by a heterologous insert prime-boost vaccine regimen in rhesus monkeysDavid R Kaufman
Division of Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02215, United States
Vaccine 30:506-9. 2012..These data suggest that antigen-independent factors contribute to the immunodominance patterns of vaccine-elicited cellular immune responses...
Structural constraints on viral escape from HIV- and SIV-specific cytotoxic T-lymphocytesFred W Peyerl
Division of Viral Pathogenesis, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA
Viral Immunol 17:144-51. 2004....
Robust vaccine-elicited cellular immune responses in breast milk following systemic simian immunodeficiency virus DNA prime and live virus vector boost vaccination of lactating rhesus monkeysAndrew B Wilks
Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA
J Immunol 185:7097-106. 2010....
Multiple innate immune pathways contribute to the immunogenicity of recombinant adenovirus vaccine vectorsElizabeth G Rhee
Division of Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA
J Virol 85:315-23. 2011..Stimulation of multiple innate immune mechanisms may prove a generalizable property of potent vaccines, and this strategy could be harnessed in the development of next-generation vaccine vectors and adjuvants...
Breadth of neutralizing antibodies elicited by stable, homogeneous clade A and clade C HIV-1 gp140 envelope trimers in guinea pigsJoseph P Nkolola
Division of Vaccine Research, Beth Israel Deaconess Medical Center, E CLS 1047, 330 Brookline Avenue, Boston, MA 02215, USA
J Virol 84:3270-9. 2010....
The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responsesDan H Barouch
Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Boston, MA, USA
Immunol Rev 202:266-74. 2004..Here, we review recent advances in our understanding of cytokine biology, T-lymphocyte differentiation, and potential applications of plasmid cytokines in the rational design of improved vaccines...
Contributions of Mamu-A*01 status and TRIM5 allele expression, but not CCL3L copy number variation, to the control of SIVmac251 replication in Indian-origin rhesus monkeysSo yon Lim
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America
PLoS Genet 6:e1000997. 2010..34 or 0.36, respectively. These findings call into question the premise that CCL3L CNV is important in HIV/SIV pathogenesis...
Vitamin A deficiency impairs vaccine-elicited gastrointestinal immunityDavid R Kaufman
Division of Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
J Immunol 187:1877-83. 2011....
Viral evolution and challenges in the development of HIV vaccinesDan H Barouch
Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Research East Room 113, Boston, MA 02215, USA
Vaccine 20:A66-8. 2002..These data suggest that viral escape from CTL may prove to be a significant limitation of the current generation of CTL-based AIDS vaccines...
BK virus-associated hemorrhagic cystitis in a Human Immunodeficiency Virus-infected patientDan H Barouch
Division of Infectious Diseases, Massachusetts General Hospital, and Division of Infectious Diseases, Brigham and Women s Hospital, Boston, MA, USA
Clin Infect Dis 35:326-9. 2002....
Disseminated trichosporonosis caused by Trichosporon loubieriFrancisco M Marty
Division of Infectious Diseases, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
J Clin Microbiol 41:5317-20. 2003..Trichosporonosis is an emerging invasive fungal infection in immunosuppressed patients; a case of disseminated infection caused by Trichosporon loubieri presented confirms its role as a human pathogen...
Generation of a novel replication-incompetent adenoviral vector derived from human adenovirus type 49: manufacture on PER.C6 cells, tropism and immunogenicityAngelique A C Lemckert
Crucell Holland BV, PO Box 2048, 2301 CA Leiden, The Netherlands
J Gen Virol 87:2891-9. 2006..SIVGag vaccine. These data demonstrate the potential of a replication deficient human group D adenoviral vector for vaccination purposes...
HIV-1 vaccine candidate ineffectiveDan H Barouch
AIDS Clin Care 19:93. 2007
Cellular immunity elicited by human immunodeficiency virus type 1/ simian immunodeficiency virus DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodiesJohn R Mascola
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
J Virol 77:10348-56. 2003..These data suggest that although effector T cells can limit viral replication, they are not able to assist humoral immunity to prevent the establishment of initial infection...
Challenges in the search for an HIV vaccineAngelique A C Lemckert
Crucell Holland BV, 2301 CA Leiden, The Netherlands
Eur J Epidemiol 19:513-6. 2004..An immunogen that elicits broadly reactive neutralizing antibodies, however, has yet to be developed...
Immunogenicity of heterologous prime-boost regimens involving recombinant adenovirus serotype 11 (Ad11) and Ad35 vaccine vectors in the presence of anti-ad5 immunityAngelique A C Lemckert
Crucell Holland B. V, Leiden, The Netherlands
J Virol 79:9694-701. 2005..Nevertheless, these data suggest the potential utility of heterologous rAd prime-boost vaccine regimens using vectors derived from rare human Ad serotypes...
DNA vaccination of infants in the presence of maternal antibody: a measles model in the primateMary Premenko-Lanier
California National Primate Research Center and Department of Pathology, School of Medicine, University of California-Davis, County Road 98, Davis, CA 95616-8542, USA
Virology 307:67-75. 2003..Further, the addition of a molecular IL-2 adjuvant augments this DNA vaccine...
Adenovirus serotype 5 hexon mediates liver gene transferSimon N Waddington
Department of Haematology, Haemophilia Centre and Haemostasis Unit, Royal Free and University College Medical School, London NW3 2PF, UK
Cell 132:397-409. 2008..Liver infection by the FX-Ad5 complex is mediated through a heparin-binding exosite in the FX serine protease domain. This study reveals an unanticipated function for hexon in mediating liver gene transfer in vivo...
HIV vaccine trial canceledDan H Barouch
AIDS Clin Care 20:69. 2008
Research Grants
- Impact of HIV Envelope Conformation on ImmunogenicityBing Chen; Fiscal Year: 2010..In this proposal, we will assess the impact of HIV-1 envelope conformation on the profile of elicited neutralizing antibody responses. ..
- Impact of HIV Envelope Conformation on ImmunogenicityDAN BAROUCH; Fiscal Year: 2009..In this proposal, we will assess the impact of HIV-1 envelope conformation on the profile of elicited neutralizing antibody responses. ..
- Novel Adenovirus Vaccine Vectors for HIV/SIVDan H Barouch; Fiscal Year: 2010..abstract_text> ..
- Novel Adenovirus Vaccine Vectors for HIV/SIVDAN BAROUCH; Fiscal Year: 2009..abstract_text> ..
- Augmentation of DNA Vaccine-Elicited Immunity to HIV/SIVDAN BAROUCH; Fiscal Year: 2007..The long-term objectives of these studies are to develop novel vaccine regimens that recruit APCs to the site of inoculation in animal models and to consider advancing the most promising strategies into clinical trials. ..
- Novel Adenovirus Vaccine Vectors for HIV/SIVDAN BAROUCH; Fiscal Year: 2007....
- Cytokine-Augmented DNA Vaccine-Elicited Immunity to HIVDAN BAROUCH; Fiscal Year: 2005..Raphael Dolin, Dean for Clinical Programs, Harvard Medical School, will guide Dr. Barouch's development as an independent investigator. In addition, a committee of distinguished scientists will oversee his progress toward independence. ..
- Chimeric Adenovirus Vaccine Vectors for HIV/SIVDAN BAROUCH; Fiscal Year: 2005..Within the two-year time frame of this award, sufficient data will be generated with candidate chimeric rAd vaccines to justify further vaccine/challenge studies in rhesus monkeys. ..
